Minimal Effective Volume 90% for Double-injection Costoclavicular Block
Minimum Effective Volume of Lidocaine for Double-Injection Ultrasound-Guided Costoclavicular Block
McGill University Health Centre/Research Institute of the McGill University Health Centre
60 participants
Jun 16, 2026
INTERVENTIONAL
Conditions
Summary
In 2020, a trial demonstrated that a 2-injection technique constitutes the optimal method for the costoclavicular block. This study aims to determine the minimum amount of medication required to achieve a successful double-injection costoclavicular nerve. Block dose assignment will be done using an up-and-down sequential method, called the Biased Coin Design (BCD). The double-injection technique for US-guided costoclavicular block consists in depositing two thirds of the LA volume in the deep compartment (to anesthetize the posterior and medial cords), and one third of the injectate in the superficial compartment (to anesthetize the lateral cord). The ED90 will be calculated using isotonic regression with a 95% confidence interval derived by bootstrapping.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
ultrasound-guided double-injection costoclavicular nerve block with the same volume used in the previous successful block
Ultrasound-guided double-injection costoclavicular nerve block with lower volume than the previous successful block
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07374952